Construction of a Nomogram for Predicting Survival in Elderly Patients With Lung Adenocarcinoma: A Retrospective Cohort Study

Elderly patients with non-small-cell lung cancer (NSCLC) exhibit worse reactions to anticancer treatments. Adenocarcinoma (AC) is the predominant histologic subtype of NSCLC, is diverse and heterogeneous, and shows different outcomes and responses to treatment. The aim of this study was to establish...

Full description

Bibliographic Details
Main Authors: Haisheng You, Mengmeng Teng, Chun Xia Gao, Bo Yang, Sasa Hu, Taotao Wang, Yalin Dong, Siying Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.680679/full
_version_ 1819148413496721408
author Haisheng You
Mengmeng Teng
Chun Xia Gao
Bo Yang
Sasa Hu
Taotao Wang
Yalin Dong
Siying Chen
author_facet Haisheng You
Mengmeng Teng
Chun Xia Gao
Bo Yang
Sasa Hu
Taotao Wang
Yalin Dong
Siying Chen
author_sort Haisheng You
collection DOAJ
description Elderly patients with non-small-cell lung cancer (NSCLC) exhibit worse reactions to anticancer treatments. Adenocarcinoma (AC) is the predominant histologic subtype of NSCLC, is diverse and heterogeneous, and shows different outcomes and responses to treatment. The aim of this study was to establish a nomogram that includes the important prognostic factors based on the Surveillance, Epidemiology, and End Results (SEER) database from 2010 to 2015. We collected 53,694 patients of older than 60 who have been diagnosed with lung AC from the SEER database. Univariate and multivariate Cox regression analyses were used to screen the independent prognostic factors, which were used to construct a nomogram for predicting survival rates in elderly AC patients. The nomogram was evaluated using the concordance index (C-index), calibration curves, net reclassification index (NRI), integrated discrimination improvement (IDI), and decision-curve analysis (DCA). Elderly AC patients were randomly divided into a training cohort and validation cohort. The nomogram model included the following 11 prognostic factors: age, sex, race, marital status, tumor site, histologic grade, American Joint Committee for Cancer (AJCC) stage, surgery status, radiotherapy status, chemotherapy status, and insurance type. The C-indexes of the training and validation cohorts for cancer-specific survival (CSS) (0.832 and 0.832, respectively) based on the nomogram model were higher than those of the AJCC model (0.777 and 0.774, respectively). The CSS discrimination performance as indicated by the AUC was better in the nomogram model than the AJCC model at 1, 3, and 5 years in both the training cohort (0.888 vs. 0.833, 0.887 vs. 0.837, and 0.876 vs. 0.830, respectively) and the validation cohort (0.890 vs. 0.832, 0.883 vs. 0.834, and 0.880 vs. 0.831, respectively). The predicted CSS probabilities showed optimal agreement with the actual observations in nomogram calibration plots. The NRI, IDI, and DCA for the 1-, 3-, and 5-year follow-up examinations verified the clinical usability and practical decision-making effects of the new model. We have developed a reliable nomogram for determining the prognosis of elderly AC patients, which demonstrated excellent discrimination and clinical usability and more accurate prognosis predictions. The nomogram may improve clinical decision-making and prognosis predictions for elderly AC patients.
first_indexed 2024-12-22T13:45:19Z
format Article
id doaj.art-cf4bba02c73041c2a880dbef2a934d02
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-12-22T13:45:19Z
publishDate 2021-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-cf4bba02c73041c2a880dbef2a934d022022-12-21T18:23:48ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2021-07-01810.3389/fmed.2021.680679680679Construction of a Nomogram for Predicting Survival in Elderly Patients With Lung Adenocarcinoma: A Retrospective Cohort StudyHaisheng YouMengmeng TengChun Xia GaoBo YangSasa HuTaotao WangYalin DongSiying ChenElderly patients with non-small-cell lung cancer (NSCLC) exhibit worse reactions to anticancer treatments. Adenocarcinoma (AC) is the predominant histologic subtype of NSCLC, is diverse and heterogeneous, and shows different outcomes and responses to treatment. The aim of this study was to establish a nomogram that includes the important prognostic factors based on the Surveillance, Epidemiology, and End Results (SEER) database from 2010 to 2015. We collected 53,694 patients of older than 60 who have been diagnosed with lung AC from the SEER database. Univariate and multivariate Cox regression analyses were used to screen the independent prognostic factors, which were used to construct a nomogram for predicting survival rates in elderly AC patients. The nomogram was evaluated using the concordance index (C-index), calibration curves, net reclassification index (NRI), integrated discrimination improvement (IDI), and decision-curve analysis (DCA). Elderly AC patients were randomly divided into a training cohort and validation cohort. The nomogram model included the following 11 prognostic factors: age, sex, race, marital status, tumor site, histologic grade, American Joint Committee for Cancer (AJCC) stage, surgery status, radiotherapy status, chemotherapy status, and insurance type. The C-indexes of the training and validation cohorts for cancer-specific survival (CSS) (0.832 and 0.832, respectively) based on the nomogram model were higher than those of the AJCC model (0.777 and 0.774, respectively). The CSS discrimination performance as indicated by the AUC was better in the nomogram model than the AJCC model at 1, 3, and 5 years in both the training cohort (0.888 vs. 0.833, 0.887 vs. 0.837, and 0.876 vs. 0.830, respectively) and the validation cohort (0.890 vs. 0.832, 0.883 vs. 0.834, and 0.880 vs. 0.831, respectively). The predicted CSS probabilities showed optimal agreement with the actual observations in nomogram calibration plots. The NRI, IDI, and DCA for the 1-, 3-, and 5-year follow-up examinations verified the clinical usability and practical decision-making effects of the new model. We have developed a reliable nomogram for determining the prognosis of elderly AC patients, which demonstrated excellent discrimination and clinical usability and more accurate prognosis predictions. The nomogram may improve clinical decision-making and prognosis predictions for elderly AC patients.https://www.frontiersin.org/articles/10.3389/fmed.2021.680679/fullnon-small-cell lung canceradenocarcinomanomogramelderly patientssurvival prediction
spellingShingle Haisheng You
Mengmeng Teng
Chun Xia Gao
Bo Yang
Sasa Hu
Taotao Wang
Yalin Dong
Siying Chen
Construction of a Nomogram for Predicting Survival in Elderly Patients With Lung Adenocarcinoma: A Retrospective Cohort Study
Frontiers in Medicine
non-small-cell lung cancer
adenocarcinoma
nomogram
elderly patients
survival prediction
title Construction of a Nomogram for Predicting Survival in Elderly Patients With Lung Adenocarcinoma: A Retrospective Cohort Study
title_full Construction of a Nomogram for Predicting Survival in Elderly Patients With Lung Adenocarcinoma: A Retrospective Cohort Study
title_fullStr Construction of a Nomogram for Predicting Survival in Elderly Patients With Lung Adenocarcinoma: A Retrospective Cohort Study
title_full_unstemmed Construction of a Nomogram for Predicting Survival in Elderly Patients With Lung Adenocarcinoma: A Retrospective Cohort Study
title_short Construction of a Nomogram for Predicting Survival in Elderly Patients With Lung Adenocarcinoma: A Retrospective Cohort Study
title_sort construction of a nomogram for predicting survival in elderly patients with lung adenocarcinoma a retrospective cohort study
topic non-small-cell lung cancer
adenocarcinoma
nomogram
elderly patients
survival prediction
url https://www.frontiersin.org/articles/10.3389/fmed.2021.680679/full
work_keys_str_mv AT haishengyou constructionofanomogramforpredictingsurvivalinelderlypatientswithlungadenocarcinomaaretrospectivecohortstudy
AT mengmengteng constructionofanomogramforpredictingsurvivalinelderlypatientswithlungadenocarcinomaaretrospectivecohortstudy
AT chunxiagao constructionofanomogramforpredictingsurvivalinelderlypatientswithlungadenocarcinomaaretrospectivecohortstudy
AT boyang constructionofanomogramforpredictingsurvivalinelderlypatientswithlungadenocarcinomaaretrospectivecohortstudy
AT sasahu constructionofanomogramforpredictingsurvivalinelderlypatientswithlungadenocarcinomaaretrospectivecohortstudy
AT taotaowang constructionofanomogramforpredictingsurvivalinelderlypatientswithlungadenocarcinomaaretrospectivecohortstudy
AT yalindong constructionofanomogramforpredictingsurvivalinelderlypatientswithlungadenocarcinomaaretrospectivecohortstudy
AT siyingchen constructionofanomogramforpredictingsurvivalinelderlypatientswithlungadenocarcinomaaretrospectivecohortstudy